BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37209463)

  • 1. Magnetic resonance fingerprinting based comprehensive quantification of T1 and T2 values of the background prostatic peripheral zone: Correlation with clinical and demographic features.
    de Oliveira Correia ET; Qiao PL; Griswold MA; Chen Y; Bittencourt LK
    Eur J Radiol; 2023 Jul; 164():110883. PubMed ID: 37209463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
    Shiradkar R; Panda A; Leo P; Janowczyk A; Farre X; Janaki N; Li L; Pahwa S; Mahran A; Buzzy C; Fu P; Elliott R; MacLennan G; Ponsky L; Gulani V; Madabhushi A
    Eur Radiol; 2021 Mar; 31(3):1336-1346. PubMed ID: 32876839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
    Lee YS; Choi MH; Lee YJ; Han D; Kim DH
    Br J Radiol; 2022 Mar; 95(1131):20210479. PubMed ID: 34415785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
    Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
    Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies.
    Han D; Choi MH; Lee YJ; Kim DH
    Korean J Radiol; 2021 Aug; 22(8):1332-1340. PubMed ID: 34047506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]   [Full Text] [Related]  

  • 7. Multicenter Repeatability and Reproducibility of MR Fingerprinting in Phantoms and in Prostatic Tissue.
    Lo WC; Bittencourt LK; Panda A; Jiang Y; Tokuda J; Seethamraju R; Tempany-Afdhal C; Obmann V; Wright K; Griswold M; Seiberlich N; Gulani V
    Magn Reson Med; 2022 Oct; 88(4):1818-1827. PubMed ID: 35713379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Analysis of Prostate MRI: Correlation between Contrast-Enhanced Magnetic Resonance Fingerprinting and Dynamic Contrast-Enhanced MRI Parameters.
    Choi MH; Lee YJ; Han D; Kim DH
    Curr Oncol; 2023 Dec; 30(12):10299-10310. PubMed ID: 38132384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
    Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
    Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D MR fingerprinting (MRF) for simultaneous T1 and T2 quantification of the bone metastasis: Initial validation in prostate cancer patients.
    Choi MH; Lee SW; Kim HG; Kim JY; Oh SW; Han D; Kim DH
    Eur J Radiol; 2021 Nov; 144():109990. PubMed ID: 34638082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant changes of T2 value in the peripheral zone and seminal vesicles after ejaculation.
    Shin T; Kaji Y; Shukuya T; Nozaki M; Soh S; Okada H
    Eur Radiol; 2018 Mar; 28(3):1009-1015. PubMed ID: 28986624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.
    Fedorov A; Vangel MG; Tempany CM; Fennessy FM
    Invest Radiol; 2017 Sep; 52(9):538-546. PubMed ID: 28463931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of T
    Klingebiel M; Schimmöller L; Weiland E; Franiel T; Jannusch K; Kirchner J; Hilbert T; Strecker R; Arsov C; Wittsack HJ; Albers P; Antoch G; Ullrich T
    J Magn Reson Imaging; 2022 Aug; 56(2):413-422. PubMed ID: 35038203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
    Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
    Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
    Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
    Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR fingerprinting of the prostate.
    Lo WC; Panda A; Jiang Y; Ahad J; Gulani V; Seiberlich N
    MAGMA; 2022 Aug; 35(4):557-571. PubMed ID: 35419668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
    Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
    Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.
    Yu AC; Badve C; Ponsky LE; Pahwa S; Dastmalchian S; Rogers M; Jiang Y; Margevicius S; Schluchter M; Tabayoyong W; Abouassaly R; McGivney D; Griswold MA; Gulani V
    Radiology; 2017 Jun; 283(3):729-738. PubMed ID: 28187264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
    Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
    Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
    Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
    J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.